Ectodomain shedding of preadipocyte factor 1 (Pref-1) by tumor necrosis factor alpha converting enzyme (TACE) and inhibition of adipocyte differentiation

被引:103
作者
Wang, Yuhui [1 ]
Sul, He Sook [1 ]
机构
[1] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA
关键词
ACTIVATED-RECEPTOR-GAMMA; GROWTH-FACTOR-ALPHA; FACTOR-I PREF-1; ANTIGEN; FA1; CELL-SURFACE; MAP KINASE; TRANSMEMBRANE PROTEINS; PROMOTES ADIPOGENESIS; 3T3-L1; PREADIPOCYTES; SOLUBLE FORM;
D O I
10.1128/MCB.02437-05
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Preadipocyte factor 1 (Pref-1), an epidermal growth factor repeat containing transmembrane protein found in the preadipocytes, inhibits adipocyte differentiation in vitro and in vivo. Here, we examined the processing of membrane form of Pref-IA to release the 50-kDa soluble form that inhibits adipocyte differentiation. The ectodomain cleavage of Pref-1 is markedly enhanced by phorbol 12-myristate 13-acetate in a dose- and time-dependent manner. The basal and stimulated cleavage is inhibited by the broad metalloproteinase inhibitor GM6001, a fact that suggests that cleavage of membrane Pref-IA is dependent on a metalloproteinase. Next, we showed that release of soluble Pref-1A is inhibited by TAPI-0 and by a tissue inhibitor of metalloproteinase-3, TIMP-3, that can inhibit tumor necrosis factor alpha converting enzyme (TACE), but not by TIMP-1 or TIMP-2. On the other hand, overexpression of TACE increases Pref-1 cleavage to produce the 50-kDa soluble form. Furthermore, this cleavage was not detected in cells with TACE mutation or with TACE small interfering RNA. TACE-mediated shedding of Pref-1 ectodomain inhibits adipocyte differentiation of 3T3-L1 cells and in Pref-1-null mouse embryo fibroblasts transduced with Pref-IA. Identification of TACE as the major protease responsible for conversion of membrane-bound Pref-1 to the biologically active diffusible form provides a new insight into Pref-1 function in adipocyte differentiation.
引用
收藏
页码:5421 / 5435
页数:15
相关论文
共 79 条
[31]   Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-α-converting enzyme (ADAM 17) [J].
Garton, KJ ;
Gough, PJ ;
Philalay, J ;
Wille, PT ;
Blobel, CP ;
Whitehead, RH ;
Dempsey, PJ ;
Raines, EW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37459-37464
[32]  
Garton KJ, 2001, J BIOL CHEM, V276, P37993
[33]   Understanding adipocyte differentiation [J].
Gregoire, FM ;
Smas, CM ;
Sul, HS .
PHYSIOLOGICAL REVIEWS, 1998, 78 (03) :783-809
[34]   Deregulated MAPK activity prevents adipocyte differentiation of fibroblasts lacking the retinoblastoma protein [J].
Hansen, JB ;
Petersen, RK ;
Jorgensen, C ;
Kristiansen, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (29) :26335-26339
[35]   Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation [J].
Hansen, LH ;
Madsen, B ;
Teisner, B ;
Nielsen, JH ;
Billestrup, N .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (08) :1140-1149
[36]   Membrane protein secretases [J].
Hooper, NM ;
Karran, EH ;
Turner, AJ .
BIOCHEMICAL JOURNAL, 1997, 321 :265-279
[37]   Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR gamma [J].
Hu, ED ;
Kim, JB ;
Sarraf, P ;
Spiegelman, BM .
SCIENCE, 1996, 274 (5295) :2100-2103
[38]   Shedding light on ADAM metalloproteinases [J].
Huovila, APJ ;
Turner, AJ ;
Pelto-Huikko, M ;
Kärkkäinen, L ;
Ortiz, RM .
TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (07) :413-422
[39]   A metalloprotease-disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor [J].
Izumi, Y ;
Hirata, M ;
Hasuwa, H ;
Iwamoto, R ;
Umata, T ;
Miyado, K ;
Tamai, Y ;
Kurisaki, T ;
Sehara-Fujisawa, A ;
Ohno, S ;
Mekada, E .
EMBO JOURNAL, 1998, 17 (24) :7260-7272
[40]   Fetal antigen 1 (FA1), a circulating member of the epidermal growth factor (EGF) superfamily: ELISA development, physiology and metabolism in relation to renal function [J].
Jensen, CH ;
Krogh, TN ;
Stoving, RK ;
Holmskov, U ;
Teisner, B .
CLINICA CHIMICA ACTA, 1997, 268 (1-2) :1-20